United Services Automobile Association’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,284
Closed -$469K 2303
2018
Q4
$469K Sell
1,284
-96
-7% -$51.6K ﹤0.01% 1585
2018
Q3
$932K Sell
1,380
-22
-2% -$15.6K ﹤0.01% 1384
2018
Q2
$1.22M Sell
1,402
-17
-1% -$19.5K ﹤0.01% 1282
2018
Q1
$1.78M Buy
1,419
+972
+217% +$1.44M ﹤0.01% 1159
2017
Q4
$668K Buy
447
+20
+5% +$31.6K ﹤0.01% 1333
2017
Q3
$873K Buy
427
+11
+3% +$25.8K ﹤0.01% 1222
2017
Q2
$1.17M Buy
416
+18
+5% +$46.4K ﹤0.01% 1140
2017
Q1
$1.19M Sell
398
-9
-2% -$21.9K ﹤0.01% 1073
2016
Q4
$605K Hold
407
﹤0.01% 1179
2016
Q3
$725K Sell
407
-19
-4% -$36.7K ﹤0.01% 1149
2016
Q2
$799K Sell
426
-68
-14% -$137K ﹤0.01% 1099
2016
Q1
$1.11M Hold
494
﹤0.01% 1048
2015
Q4
$1.18M Buy
494
+86
+21% +$210K ﹤0.01% 1050
2015
Q3
$969K Buy
+408
New +$1.08M ﹤0.01% 1068

Other funds holding NBRV

United Services Automobile Association's NBRV Position: Q1 2019 in Review

United Services Automobile Association sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2019, closing a stake of 1,284 shares — an estimated $469K sold.

United Services Automobile Association first reported a position in NBRV in Q3 2015 and held it in 14 quarters. The position peaked at $1.78M in Q1 2018. 39 funds tracked by Wall St. Rank hold NBRV as of Q1 2019.

  • United Services Automobile Association reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2019 after selling out during the quarter.
  • United Services Automobile Association sold 1,284 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2019, an estimated $469K.
  • United Services Automobile Association first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 14 quarters.
  • United Services Automobile Association's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.78M in Q1 2018.
  • 39 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2019.

Based on United Services Automobile Association's 13F filing for Q1 2019, filed 13 May 2019.